This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Gangneung-Wonju National University Industry Academy Cooperation Group, Kyungpook National University Industry-Academic Cooperation Foundation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 20 
1 out of 365 Years Active: 2025
Title: Innovations of Dong-Kyo Lee in Bone Disease Treatment
Introduction
Dong-Kyo Lee is a notable inventor based in Changwon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of bone diseases. His innovative work has the potential to improve the quality of life for individuals suffering from various bone-related conditions.
Latest Patents
Dong-Kyo Lee holds a patent for a pharmaceutical composition that comprises 4-hexylresorcinol as an active ingredient for the prevention or treatment of bone disease. This invention relates to a composition that utilizes 4-hexylresorcinol (4-HR) to enhance bone thickness, density, and strength. The formulation has been shown to control bone remodeling by promoting the differentiation of osteoblasts while suppressing the proliferation and differentiation of osteoclasts in osteoporosis-induced animal models. Consequently, this composition can serve as a therapeutic agent for bone diseases, including bone fractures, osteoarthritis, rheumatoid arthritis, and osteoporosis. He has 1 patent to his name.
Career Highlights
Throughout his career, Dong-Kyo Lee has been associated with prominent institutions such as the Kyungpook National University Industry-Academic Cooperation Foundation and the Gangneung-Wonju National University Industry Academy Cooperation Group. His work in these organizations has allowed him to collaborate with other experts in the field and further his research on bone health.
Collaborations
Dong-Kyo Lee has worked alongside notable colleagues, including Je-Yong Choi and Xiangguo Che. Their collaborative efforts have contributed to advancements in the understanding and treatment of bone diseases.
Conclusion
Dong-Kyo Lee's innovative contributions to the pharmaceutical field, particularly in the treatment of bone diseases, highlight the importance of research and development in improving health outcomes. His work continues to pave the way for new therapeutic options for patients suffering from bone-related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile